Benefit of Dapagliflozin When Used With Cardiovascular Medications in Patients With Type 2 Diabetes

被引：0
|
作者：
Slomski, Anita
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 328卷 / 09期
关键词：
D O I：
10.1001/jama.2022.14696
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：817 / 817
页数：1
相关论文
共 50 条
  • [41] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Donald Elliott Kohan
    Paola Fioretto
    Kristina Johnsson
    Shamik Parikh
    Agata Ptaszynska
    Lisa Ying
    [J]. Journal of Nephrology, 2016, 29 : 391 - 400
  • [42] Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes
    Plosker, Greg L.
    [J]. DRUGS, 2014, 74 (18) : 2191 - 2209
  • [43] EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD
    Abdullaev, Sherzod
    Sharapov, Olimkhon
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I685 - I686
  • [44] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Kohan, Donald Elliott
    Fioretto, Paola
    Johnsson, Kristina
    Parikh, Shamik
    Ptaszynska, Agata
    Ying, Lisa
    [J]. JOURNAL OF NEPHROLOGY, 2016, 29 (03) : 391 - 400
  • [45] Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes
    Bletsa, Evdoxia
    Filippas-Dekouan, Sebastien
    Kostara, Christina
    Dafopoulos, Panagiotis
    Dimou, Aikaterini
    Pappa, Eleni
    Chasapi, Styliani
    Spyroulias, Georgios
    Koutsovasilis, Anastasios
    Bairaktari, Eleni
    Ferrannini, Ele
    Tsimihodimos, Vasilis
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05): : 1269 - 1283
  • [46] Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes
    Greg L. Plosker
    [J]. Drugs, 2014, 74 : 2191 - 2209
  • [47] Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
    Mccoy, Rozalina G.
    Herrin, Jeph
    Swarna, Kavya Sindhu
    Deng, Yihong
    Kent, David M.
    Ross, Joseph S.
    Umpierrez, Guillermo E.
    Galindo, Rodolfo J.
    Crown, William H.
    Borah, Bijan J.
    Montori, Victor M.
    Brito, Juan P.
    Neumiller, Joshua J.
    Mickelson, Mindy M.
    Polley, Eric C.
    [J]. NATURE CARDIOVASCULAR RESEARCH, 2024, 3 (04): : 431 - 440
  • [48] Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
    Rozalina G. McCoy
    Jeph Herrin
    Kavya Sindhu Swarna
    Yihong Deng
    David M. Kent
    Joseph S. Ross
    Guillermo E. Umpierrez
    Rodolfo J. Galindo
    William H. Crown
    Bijan J. Borah
    Victor M. Montori
    Juan P. Brito
    Joshua J. Neumiller
    Mindy M. Mickelson
    Eric C. Polley
    [J]. Nature Cardiovascular Research, 2024, 3 : 431 - 440
  • [49] Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?
    Paul D. Rosenblit
    [J]. Cardiovascular Diabetology, 15
  • [50] Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?
    Rosenblit, Paul D.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2016, 15
12345